IOWA ONCOLOGY RESEARCH ASSOCIATION (EIN 421104334) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1978

Legal Domicile

Principal Officer

ARSHIN SHEYBANI MD

Phone

5152447586

Tax Period

2024-08-01 to 2025-07-31

IOWA ONCOLOGY RESEARCH ASSOCIATION, founded in 1978, is a community nonprofit in the Medical Research sector that reported $1.7M in total revenue in fiscal year 2024.

Mission

TO BE ENGAGED IN THE PURSUIT OF BASIC AND CLINICAL ONCOLOGICAL RESEARCH, WHILE PROMOTING OPTIMAL AND COMPREHENSIVE CARE FOR THE ONCOLOGY PATIENTS IN IOWA. THE ORGANIZATION IS FOUNDED ON THE PREMISES THAT HIGH QUALITY CLINICAL CANCER TREATMENT, CANCER CARE DELIVERY RESEARCH, AND CANCER CONTROL RESEARCH CAN BE CONDUCTED IN THE COMMUNITY BY ONCOLOGY PHYSICIANS, ONCOLOGY NURSE SPECIALISTS, CLINICAL RESEARCH ASSOCIATES, AND THAT THE COMMUNITY VENUE PROVIDES THE ULTIMATE PROVING GROUND FOR APPLICABILITY AND GENERALIZABILITY OF NEW CANCER TREATMENTS AND PREVENTION STRATEGIES FOR THE GENERAL POPULATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $1,441,964

Program Service Revenue $232,271

Investment Income $18

Other Revenue $3,000

TOTAL REVENUE $1,677,253

Expense Breakdown

Grants Paid $530,564

Salaries & Benefits $976,960

Fundraising Expenses $0

Program Expenses $1,442,670

Other Expenses $245,795

TOTAL EXPENSES $1,753,319

Year-over-Year Comparison

	2024	2023	Change
Revenue	$1,677,253	$1,578,577	+0.1%
Expenses	$1,753,319	$1,733,959	+0.0%
Net Income	$-76,066	$-155,382	-0.5%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOSHUA LUKENBILL	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
DEBORAH WILBUR MD	VICE-PRESIDENT	5.00	Officer Director	$0	$0	$0
WENDY WOODS-SWAFFORD MD	TREASURER	5.00	Officer Director	$0	$0	$0
JOSEPH MERCHANT	SECRETARY	5.00	Officer Director	$0	$0	$0
ROBERT BEHRENS	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
MICHAEL MARQUARDT	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
KATY JUHL PHARMD	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
ABDELAZIZ ELHADDAD	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
BHARAT JENIGIRI	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
MARK KELLERMAN	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
ARSHIN SHEYBANI MD	CO-PRESIDENT AND CO-PRINCI	5.00	Officer Director	$0	$0	$0
HARICHAND-HERDT MD	CO-PRESIDENT AND CO-PRINCI	5.00	Officer Director	$0	$0	$0
RICHARD DEMING MD	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0
JESSICA PARKHURST MD	MEMBER-AT-LARGE	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$1,677,253	$1,753,319	$398,855	$-76,066
2024	$1,578,577	$1,733,959	$433,648	$-155,382
2023	$1,714,782	$1,759,029	$583,299	$-44,247
2022	$1,300,527	$1,465,255	$652,663	$-164,728
2021	$1,474,377	$1,364,730	$821,521	$109,647
2020	$1,388,083	$1,200,089	$766,683	$187,994
2019	$1,387,063	$1,081,676	$513,473	$305,387

IOWA ONCOLOGY RESEARCH ASSOCIATION